Pro to Gly (P219G) in a Silent Glycosylation Site Results in Complete Glycosylation in Tissue Plasminogen Activator

Overview

Journal Protein Sci

Specialty Biochemistry

Date 1993 Jan 1

PMID 8443586

Citations 1

Authors

D T Berg

B W Grinnell

Affiliations

Soon will be listed here.

Citing Articles

Substitution of asparagine residues in Aspergillus awamori glucoamylase by site-directed mutagenesis to eliminate N-glycosylation and inactivation by deamidation.

Chen H, Ford C, Reilly P Biochem J. 1994; 301 ( Pt 1):275-81.

PMID: 8037681 PMC: 1137172. DOI: 10.1042/bj3010275.

References

Marshall R . The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins. Biochem Soc Symp. 1974; (40):17-26. View

Torano A, TSUZUKIDA Y, Liu Y, Putnam F . Location and structural significance of the oligosaccharides in human Ig-A1 and IgA2 immunoglobulins. Proc Natl Acad Sci U S A. 1977; 74(6):2301-5. PMC: 432158. DOI: 10.1073/pnas.74.6.2301. View

BAUSE E . Studies on the acceptor specificity of asparagine-N-glycosyl-transferase from rat liver. FEBS Lett. 1979; 103(2):296-9. DOI: 10.1016/0014-5793(79)81348-4. View

Kunkel T . Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985; 82(2):488-92. PMC: 397064. DOI: 10.1073/pnas.82.2.488. View

Little S, Bang N, Harms C, Marks C, Mattler L . Functional properties of carbohydrate-depleted tissue plasminogen activator. Biochemistry. 1984; 23(25):6191-5. DOI: 10.1021/bi00320a046. View

Tarentino A, Gomez C, PLUMMER Jr T . Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. Biochemistry. 1985; 24(17):4665-71. DOI: 10.1021/bi00338a028. View

Stenflo J, Fernlund P . Amino acid sequence of the heavy chain of bovine protein C. J Biol Chem. 1982; 257(20):12180-90. View

Kunkel T, Roberts J, Zakour R . Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987; 154:367-82. DOI: 10.1016/0076-6879(87)54085-x. View

Gurewich V . Importance of fibrin specificity in therapeutic thrombolysis and the rationale of using sequential and synergistic combinations of tissue plasminogen activator and pro-urokinase. Semin Thromb Hemost. 1989; 15(2):123-8. DOI: 10.1055/s-2007-1002694. View

10.

Collen D, Lijnen H, Todd P, Goa K . Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent. Drugs. 1989; 38(3):346-88. DOI: 10.2165/00003495-198938030-00003. View

11.

Burck P, Berg D, Warrick M, Berg D, Walls J, Jaskunas S . Characterization of a modified human tissue plasminogen activator comprising a kringle-2 and a protease domain. J Biol Chem. 1990; 265(9):5170-7. View

12.

Grinnell B, Walls J, Gerlitz B . Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. J Biol Chem. 1991; 266(15):9778-85. View

13.

Berg D, Grinnell B . Signal and propeptide processing of human tissue plasminogen activator: activity of a pro-tPA derivative. Biochem Biophys Res Commun. 1991; 179(3):1289-96. DOI: 10.1016/0006-291x(91)91713-m. View

14.

Titani K, Kumar S, Takio K, Ericsson L, WADE R, Ashida K . Amino acid sequence of human von Willebrand factor. Biochemistry. 1986; 25(11):3171-84. DOI: 10.1021/bi00359a015. View